Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine (EFdA)-Suppressed Humanized Mice

por Maidji, Ekaterina, Moreno, Mary E., Rivera, Jose M., Joshi, Pheroze, Galkina, Sofiya A., Kosikova, Galina, Somsouk, Ma, Stoddart, Cheryl A.
Publicado en Viruses (2019)

Superior Human Leukocyte Reconstitution and Susceptibility to Vaginal HIV Transmission in Humanized NOD-scid IL-2R (−/−) (NSG) BLT Mice

por Stoddart, Cheryl A., Maidji, Ekaterina, Galkina, Sofiya A., Kosikova, Galina, Rivera, Jose M., Moreno, Mary E., Sloan, Barbara, Joshi, Pheroze, Long, Brian R.
Publicado 2011

Genetically edited CD34(+) cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells

por Morvan, Maelig G., Teque, Fernando, Ye, Lin, Moreno, Mary E., Wang, Jiaming, VandenBerg, Scott, Stoddart, Cheryl A., Kan, Yuet Wai, Levy, Jay A.
Publicado en Proc Natl Acad Sci U S A (2021)

R5 Strains of Human Immunodeficiency Virus Type 1 from Rapid Progressors Lacking X4 Strains Do Not Possess X4-Type Pathogenicity in Human Thymus

por Berkowitz, Robert D., van ’t Wout, Angélique B., Kootstra, Neeltje A., Moreno, Mary E., Linquist-Stepps, Valerie D., Bare, Christopher, Stoddart, Cheryl A., Schuitemaker, Hanneke, McCune, Joseph M.
Publicado 1999

Antiviral Activity of 2′-Deoxy-3′-Oxa-4′-Thiocytidine (BCH-10652) against Lamivudine-Resistant Human Immunodeficiency Virus Type 1 in SCID-hu Thy/Liv Mice

por Stoddart, Cheryl A., Moreno, Mary E., Linquist-Stepps, Valerie D., Bare, Christopher, Bogan, Mark R., Gobbi, Alberto, Buckheit, Robert W., Bedard, Jean, Rando, Robert F., McCune, Joseph M.
Publicado 2000

Inhibition of Human Immunodeficiency Virus Type 1 Infection in SCID-hu Thy/Liv Mice by the G-Quartet-Forming Oligonucleotide, ISIS 5320

por Stoddart, Cheryl A., Rabin, Linda, Hincenbergs, Mara, Moreno, Mary e., Linquist-Stepps, Valerie, Leeds, Janet M., Truong, Lo Anne, Wyatt, J. R., Ecker, David J., McCune, Joseph M.
Publicado 1998

CCR5- and CXCR4-Utilizing Strains of Human Immunodeficiency Virus Type 1 Exhibit Differential Tropism and Pathogenesis In Vivo

por Berkowitz, Robert D., Alexander, Sabina, Bare, Cris, Linquist-Stepps, Valerie, Bogan, Mark, Moreno, Mary E., Gibson, Lisa, Wieder, Eric D., Kosek, Jon, Stoddart, Cheryl A., McCune, Joseph M.
Publicado 1998

Human Immunodeficiency Virus Type 1 Nef-Mediated Downregulation of CD4 Correlates with Nef Enhancement of Viral Pathogenesis

por Stoddart, Cheryl A., Geleziunas, Romas, Ferrell, Sharon, Linquist-Stepps, Valerie, Moreno, Mary E., Bare, Christopher, Xu, Weiduan, Yonemoto, Wes, Bresnahan, Patricia A., McCune, Joseph M., Greene, Warner C.
Publicado 2003

Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Propert...

por Stoddart, Cheryl A., Galkina, Sofiya A., Joshi, Pheroze, Kosikova, Galina, Moreno, Mary E., Rivera, Jose M., Sloan, Barbara, Reeve, Aaron B., Sarafianos, Stefan G., Murphey-Corb, Michael, Parniak, Michael A.
Publicado en Antimicrob Agents Chemother (2015)

Coinfection of SCID-hu Thy/Liv Mice with Human Herpesvirus 6 and Human Immunodeficiency Virus Type 1

por Gobbi, Alberto, Stoddart, Cheryl A., Locatelli, Giuseppe, Santoro, Fabio, Bare, Christopher, Linquist-Stepps, Valerie, Moreno, Mary E., Abbey, Nancy W., Herndier, Brian G., Malnati, Mauro S., McCune, Joseph M., Lusso, Paolo
Publicado 2000

Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals

por Stoddart, Cheryl A., Bales, Cheryl A., Bare, Jennifer C., Chkhenkeli, George, Galkina, Sofiya A., Kinkade, April N., Moreno, Mary E., Rivera, José M., Ronquillo, Rollie E., Sloan, Barbara, Black, Paul L.
Publicado 2007

Efficacy of Broadly Neutralizing Monoclonal Antibody PG16 in HIV-infected Humanized Mice

por Stoddart, Cheryl A., Galkina, Sofiya A., Joshi, Pheroze, Kosikova, Galina, Long, Brian R., Maidji, Ekaterina, Moreno, Mary E., Rivera, Jose M., Sanford, Ukina R., Sloan, Barbara, Cieplak, Witold, Wrin, Terri, Chan-Hui, Po-Ying
Publicado 2014

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

por Strizki, Julie M., Xu, Serena, Wagner, Nicole E., Wojcik, Lisa, Liu, Jia, Hou, Yan, Endres, Michael, Palani, Anandan, Shapiro, Sherry, Clader, John W., Greenlee, William J., Tagat, Jayaram R., McCombie, Stuart, Cox, Kathleen, Fawzi, Ahmad B., Chou, Chuan-Chu, Pugliese-Sivo, Catherine, Davies, Liza, Moreno, Mary E., Ho, David D., Trkola, Alexandra, Stoddart, Cheryl A., Moore, John P., Reyes, Gregory R., Baroudy, Bahige M.
Publicado 2001

Test performance evaluation of SARS-CoV-2 serological assays

por Whitman, Jeffrey D., Hiatt, Joseph, Mowery, Cody T., Shy, Brian R., Yu, Ruby, Yamamoto, Tori N., Rathore, Ujjwal, Goldgof, Gregory M., Whitty, Caroline, Woo, Jonathan M., Gallman, Antonia E., Miller, Tyler E., Levine, Andrew G., Nguyen, David N., Bapat, Sagar P., Balcerek, Joanna, Bylsma, Sophia A., Lyons, Ana M., Li, Stacy, Wong, Allison Wai-yi, Gillis-Buck, Eva Mae, Steinhart, Zachary B., Lee, Youjin, Apathy, Ryan, Lipke, Mitchell J., Smith, Jennifer Anne, Zheng, Tina, Boothby, Ian C., Isaza, Erin, Chan, Jackie, Acenas, Dante D., Lee, Jinwoo, Macrae, Trisha A., Kyaw, Than S., Wu, David, Ng, Dianna L., Gu, Wei, York, Vanessa A., Eskandarian, Haig Alexander, Callaway, Perri C., Warrier, Lakshmi, Moreno, Mary E., Levan, Justine, Torres, Leonel, Farrington, Lila A., Loudermilk, Rita, Koshal, Kanishka, Zorn, Kelsey C., Garcia-Beltran, Wilfredo F., Yang, Diane, Astudillo, Michael G., Bernstein, Bradley E., Gelfand, Jeffrey A., Ryan, Edward T., Charles, Richelle C., Iafrate, A. John, Lennerz, Jochen K., Miller, Steve, Chiu, Charles Y., Stramer, Susan L., Wilson, Michael R., Manglik, Aashish, Ye, Chun Jimmie, Krogan, Nevan J., Anderson, Mark S., Cyster, Jason G., Ernst, Joel D., Wu, Alan H. B., Lynch, Kara L., Bern, Caryn, Hsu, Patrick D., Marson, Alexander
Publicado en medRxiv (2020)

Test performance evaluation of SARS-CoV-2 serological assays

por Whitman, Jeffrey D., Hiatt, Joseph, Mowery, Cody T., Shy, Brian R., Yu, Ruby, Yamamoto, Tori N., Rathore, Ujjwal, Goldgof, Gregory M., Whitty, Caroline, Woo, Jonathan M., Gallman, Antonia E., Miller, Tyler E., Levine, Andrew G., Nguyen, David N., Bapat, Sagar P., Balcerek, Joanna, Bylsma, Sophia A., Lyons, Ana M., Li, Stacy, Wong, Allison Wai-yi, Gillis-Buck, Eva Mae, Steinhart, Zachary B., Lee, Youjin, Apathy, Ryan, Lipke, Mitchell J., Smith, Jennifer Anne, Zheng, Tina, Boothby, Ian C., Isaza, Erin, Chan, Jackie, Acenas, Dante D., Lee, Jinwoo, Macrae, Trisha A., Kyaw, Than S., Wu, David, Ng, Dianna L., Gu, Wei, York, Vanessa A., Eskandarian, Haig Alexander, Callaway, Perri C., Warrier, Lakshmi, Moreno, Mary E., Levan, Justine, Torres, Leonel, Farrington, Lila A., Loudermilk, Rita, Koshal, Kanishka, Zorn, Kelsey C., Garcia-Beltran, Wilfredo F., Yang, Diane, Astudillo, Michael G., Bernstein, Bradley E., Gelfand, Jeffrey A., Ryan, Edward T., Charles, Richelle C., Iafrate, A. John, Lennerz, Jochen K., Miller, Steve, Chiu, Charles Y., Stramer, Susan L., Wilson, Michael R., Manglik, Aashish, Ye, Chun Jimmie, Krogan, Nevan J., Anderson, Mark S., Cyster, Jason G., Ernst, Joel D., Wu, Alan H. B., Lynch, Kara L., Bern, Caryn, Hsu, Patrick D., Marson, Alexander
Publicado en Nat Biotechnol (2020)